
CannaPharmaRx Inc
OTC:CPMD

Intrinsic Value
The intrinsic value of one
CPMD
stock under the Base Case scenario is
0.001
USD.
Compared to the current market price of 0.003 USD,
CannaPharmaRx Inc
is
Overvalued by 68%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
CannaPharmaRx Inc
Loading...
Fundamental Analysis


Revenue & Expenses Breakdown
CannaPharmaRx Inc
Balance Sheet Decomposition
CannaPharmaRx Inc
Current Assets | 1.5m |
Cash & Short-Term Investments | 7k |
Receivables | 270.6k |
Other Current Assets | 1.2m |
Non-Current Assets | 10.2m |
Long-Term Investments | 4.5m |
PP&E | 5.7m |
Other Non-Current Assets | 100 |
Free Cash Flow Analysis
CannaPharmaRx Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
CannaPharmaRx Inc
Revenue
|
338k
USD
|
Cost of Revenue
|
-1.1m
USD
|
Gross Profit
|
-793.6k
USD
|
Operating Expenses
|
-141.5k
USD
|
Operating Income
|
-935.1k
USD
|
Other Expenses
|
2.3m
USD
|
Net Income
|
1.4m
USD
|
CPMD Profitability Score
Profitability Due Diligence
CannaPharmaRx Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

Score
CannaPharmaRx Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.
CPMD Solvency Score
Solvency Due Diligence
CannaPharmaRx Inc's solvency score is 29/100. The higher the solvency score, the more solvent the company is.

Score
CannaPharmaRx Inc's solvency score is 29/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CPMD Price Targets Summary
CannaPharmaRx Inc
Dividends
Current shareholder yield for CPMD is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
CPMD
stock under the Base Case scenario is
0.001
USD.
Compared to the current market price of 0.003 USD,
CannaPharmaRx Inc
is
Overvalued by 68%.